* Treace Medical Concepts Inc TMCI.OQ reported a quarterly
adjusted loss of 10 cents per share for the quarter ended in
December, lower than the same quarter last year, when the
company reported EPS of -8 cents. The mean expectation of
seven analysts for the quarter was for a loss of 9 cents per
share. Wall Street expected results to range from -15 cents
to -4 cents per share.
* Revenue rose 25% to $62.21 million from a year ago;
analysts
expected $60.55 million.
* Treace Medical Concepts Inc's reported EPS for the quarter
was a
loss of 10 cents.
* The company reported a quarterly loss of $6.28 million.
* Treace Medical Concepts Inc shares had risen by 12.4% this
quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 8.8%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Treace Medical
Concepts Inc is $15.00
This summary was machine generated from LSEG data February 28 at
02:51 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.09 -0.10 Missed
Sep. 30 2023 -0.26 -0.28 Missed
Jun. 30 2023 -0.24 -0.20 Beat
Mar. 31 2023 -0.23 -0.23 Met